News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,163 Results
Type
Article (46133)
Company Profile (306)
Press Release (723706)
Multimedia
Podcasts (145)
Webinars (28)
Section
Business (214763)
Career Advice (2247)
Deals (37213)
Drug Delivery (155)
Drug Development (84133)
Employer Resources (180)
FDA (17478)
Job Trends (15779)
News (363254)
Policy (34846)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2759)
Accelerated approval (56)
ADA (44)
Adcomms (32)
Allergies (202)
Alliances (52868)
ALS (232)
Alzheimer's disease (1884)
Antibody-drug conjugate (ADC) (531)
Approvals (17918)
Artificial intelligence (783)
ASCO (331)
Autoimmune disease (346)
Automation (66)
Bankruptcy (375)
Best Places to Work (12086)
BIO (67)
BIOSECURE Act (20)
Biosimilars (242)
Biotechnology (190)
Bladder cancer (207)
Brain cancer (78)
Breast cancer (811)
Cancer (6422)
Cardiovascular disease (517)
Career advice (1913)
Career pathing (45)
CAR-T (377)
CDC (67)
Celiac Disease (3)
Cell therapy (1021)
Cervical cancer (54)
Clinical research (73427)
Collaboration (2333)
Commercialization (1)
Company closure (5)
Compensation (1513)
Complete response letters (89)
COVID-19 (2876)
CRISPR (124)
C-suite (1270)
Cystic fibrosis (159)
Data (8695)
Decentralized trials (3)
Denatured (44)
Depression (185)
Dermatology (97)
Diabetes (688)
Diagnostics (7326)
Digital health (67)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (375)
Drug pricing (226)
Drug shortages (35)
Duchenne muscular dystrophy (313)
Earnings (95252)
Editorial (71)
Employer branding (21)
Employer resources (158)
Events (126158)
Executive appointments (1169)
FDA (21570)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1912)
Gene editing (257)
Generative AI (63)
Gene therapy (807)
GLP-1 (1185)
Government (5044)
Grass and pollen (8)
Guidances (422)
Healthcare (19958)
Hematology (195)
HIV (92)
Huntington's disease (63)
IgA nephropathy (111)
Immunology and inflammation (315)
Immuno-oncology (107)
Indications (216)
Infectious disease (3260)
Inflammatory bowel disease (227)
Inflation Reduction Act (14)
Influenza (149)
Intellectual property (325)
Interviews (353)
IPO (17198)
IRA (55)
Job creations (3998)
Job search strategy (1591)
JPM (64)
Kidney cancer (20)
Labor market (113)
Layoffs (616)
Leadership (43)
Legal (8462)
Liver cancer (108)
Longevity (37)
Lung cancer (844)
Lymphoma (476)
Machine learning (67)
Management (64)
Manufacturing (1216)
Marketing (2)
MASH (212)
Medical affairs (1)
Medical device (14835)
Medtech (15006)
Mergers & acquisitions (21340)
Metabolic disorders (1724)
mRNA (242)
Multiple sclerosis (200)
NASH (17)
Neurodegenerative disease (483)
Neuropsychiatric disorders (116)
Neuroscience (3570)
Neurotech (1)
NextGen: Class of 2026 (6890)
Non-profit (4694)
Now hiring (82)
Obesity (806)
Opinion (330)
Ovarian cancer (240)
Pain (274)
Pancreatic cancer (356)
Parkinson's disease (408)
Partnered (36)
Patents (649)
Patient recruitment (767)
Peanut (70)
People (62546)
Pharmaceutical (71)
Pharmacy benefit managers (34)
Phase 1 (22970)
Phase 2 (32297)
Phase 3 (24054)
Pipeline (9897)
Policy (362)
Postmarket research (2647)
Preclinical (9751)
Press Release (71)
Prostate cancer (343)
Psychedelics (62)
Radiopharmaceuticals (358)
Rare diseases (1214)
Real estate (6436)
Recruiting (71)
Regulatory (27337)
Reports (58)
Research institute (2548)
Resumes & cover letters (377)
Rett syndrome (44)
RNA editing (25)
RSV (94)
Schizophrenia (186)
Series A (330)
Series B (241)
Service/supplier (14)
Sickle cell disease (124)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (52)
Startups (3902)
State (2)
Stomach cancer (18)
Supply chain (142)
Tariffs (97)
The Weekly (98)
Vaccines (1217)
Venture capital (127)
Weight loss (530)
Women's health (141)
Worklife (22)
Date
Today (91)
Last 7 days (445)
Last 30 days (2777)
Last 365 days (31360)
2026 (16345)
2025 (31190)
2024 (36336)
2023 (41350)
2022 (52594)
2021 (57332)
2020 (55972)
2019 (48878)
2018 (36892)
2017 (33913)
2016 (33512)
2015 (39625)
2014 (33165)
2013 (28323)
2012 (30553)
2011 (31179)
2010 (28943)
Location
Africa (815)
Alabama (94)
Alaska (7)
Arizona (383)
Arkansas (15)
Asia (43593)
Australia (7160)
California (14190)
Canada (3983)
China (1565)
Colorado (609)
Connecticut (626)
Delaware (443)
Europe (96046)
Florida (2122)
Georgia (458)
Hawaii (4)
Idaho (67)
Illinois (1191)
India (100)
Indiana (659)
Iowa (25)
Japan (607)
Kansas (141)
Kentucky (54)
Louisiana (61)
Maine (89)
Maryland (1694)
Massachusetts (10233)
Michigan (405)
Minnesota (777)
Mississippi (7)
Missouri (162)
Montana (36)
Nebraska (30)
Nevada (153)
New Hampshire (89)
New Jersey (3741)
New Mexico (33)
New York (3705)
North Carolina (1834)
North Dakota (11)
Northern California (7178)
Ohio (435)
Oklahoma (26)
Oregon (46)
Pennsylvania (2810)
Puerto Rico (31)
Rhode Island (52)
South America (1228)
South Carolina (89)
South Dakota (2)
Southern California (5591)
Tennessee (228)
Texas (2296)
United States (50353)
Utah (426)
Vermont (2)
Virginia (366)
Washington D.C. (83)
Washington State (1142)
West Virginia (4)
Wisconsin (143)
Wyoming (2)
770,163 Results for "maxim integrated products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders
June 8, 2026
·
6 min read
Press Releases
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
June 1, 2026
·
5 min read
Press Releases
USP Publishes Product-Specific Emerging Biologics Standards for Public Comment
Advancing efficiency and alignment in biologics development, through product-specific methods, to support broader availability of biologics, including biosimilars, for patients
June 1, 2026
·
4 min read
Press Releases
AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share
May 26, 2026
·
4 min read
Press Releases
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
May 27, 2026
·
4 min read
Press Releases
NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value
April 22, 2026
·
8 min read
Press Releases
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
March 12, 2026
·
5 min read
Press Releases
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
March 25, 2026
·
5 min read
Press Releases
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
October 14, 2025
·
2 min read
Artificial intelligence
Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling
A trifecta of newly inked tech partnerships—from Eli Lilly, Bristol Myers Squibb and Incyte—exemplify the increasingly central role that AI is playing in drug development.
May 21, 2026
·
3 min read
·
Tristan Manalac
1 of 77,017
Next
